Edgar Wachenheim III
Greenhaven Associates
Edgar Wachenheim III GENPACT LTD stake
total: 102
Greenhaven Associates G trades
- Total transactions:
- 8
- New positions:
- 1
- Added:
- 3
- Reduced:
- 4
- Held since:
- 2023 Q4
- Held for:
- 11 quarters
- Latest activity:
- 2025 Q3
According to 2026 Q2 report, Edgar Wachenheim III holds 10,000 GENPACT LTD (G) shares with a market value of roughly $275.00K accounting for 0.00% of the overall portfolio. To date, the estimated cost basis is nearly $33.3 for "buy" trades and estimated average "sell" price is $49.59. Greenhaven Associates first purchased G in 2023 Q4, initially acquiring 302,805 shares. Since the initial investment in GENPACT LTD (G), Greenhaven Associates has made 7 more transactions.
When did Edgar Wachenheim III buy GENPACT LTD (G)?
Edgar Wachenheim III first invested in GENPACT LTD (G) in 2023 Q4 at the reported quarter-end price of $34.71 per share.
What's the cost basis of Greenhaven Associates's G stake?
The estimated cost basis for GENPACT LTD (G) stake is around $33.30 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $33.30
- Weighted AVG sell price:
- $49.59
Edgar Wachenheim III's historical trades in GENPACT LTD
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.01%
|
10,000
|
$41.89
|
$418,900
|
-9.24% (-1,018)
|
-0%
|
|
2025 Q2
|
0.01%
|
11,018
|
$44.01
|
$484,902
|
-92.49% (-135,660)
|
-0.09%
|
|
2025 Q1
|
0.12%
|
146,678
|
$50.38
|
$7,389,638
|
-88.08% (-1,083,660)
|
-0.81%
|
|
2024 Q4
|
0.78%
|
1,230,338
|
$42.95
|
$52,843,017
|
-1.08% (-13,475)
|
-0.01%
|
|
2024 Q3
|
0.57%
|
1,243,813
|
$39.21
|
$48,769,908
|
+0.24% (+3,038)
|
+0%
|
|
2024 Q2
|
0.52%
|
1,240,775
|
$32.19
|
$39,940,547
|
+14.08% (+153,140)
|
+0.06%
|
|
2024 Q1
|
0.33%
|
1,087,635
|
$32.95
|
$35,837,573
|
+259.19% (+784,830)
|
+0.24%
|
|
2023 Q4
|
0.11%
|
302,805
|
$34.71
|
$10,510,362
|
new
|
+0.11%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.